vs

Side-by-side financial comparison of HAEMONETICS CORP (HAE) and Western Midstream Partners, LP (WES). Click either name above to swap in a different company.

HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.3× Western Midstream Partners, LP). Western Midstream Partners, LP runs the higher net margin — 18.5% vs 7.3%, a 11.2% gap on every dollar of revenue. On growth, Western Midstream Partners, LP posted the faster year-over-year revenue change (11.0% vs 4.8%). Western Midstream Partners, LP produced more free cash flow last quarter ($335.4M vs $209.9M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs 7.8%).

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.

Sunoco LP is an American vehicle gasoline master limited partnership company organized under Delaware state law and headquartered in Dallas, Texas. Dating back to 1886, the company has transformed from a vertically integrated energy company to a distributor of fuels and operator of energy infrastructure. It was previously engaged in oil, natural gas exploration and production, refining, chemical manufacturing, and retail fuel sales, but divested these businesses.

HAE vs WES — Head-to-Head

Bigger by revenue
HAE
HAE
1.3× larger
HAE
$1.3B
$1.0B
WES
Growing faster (revenue YoY)
WES
WES
+6.2% gap
WES
11.0%
4.8%
HAE
Higher net margin
WES
WES
11.2% more per $
WES
18.5%
7.3%
HAE
More free cash flow
WES
WES
$125.5M more FCF
WES
$335.4M
$209.9M
HAE
Faster 2-yr revenue CAGR
HAE
HAE
Annualised
HAE
99.2%
7.8%
WES

Income Statement — Q4 FY2026 vs Q4 FY2025

Metric
HAE
HAE
WES
WES
Revenue
$1.3B
$1.0B
Net Profit
$97.3M
$190.7M
Gross Margin
14.9%
Operating Margin
83.4%
29.7%
Net Margin
7.3%
18.5%
Revenue YoY
4.8%
11.0%
Net Profit YoY
-42.0%
-42.8%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HAE
HAE
WES
WES
Q1 26
$1.3B
Q4 25
$339.0M
$1.0B
Q3 25
$327.3M
$952.3M
Q2 25
$321.4M
$942.1M
Q1 25
$330.6M
$916.9M
Q4 24
$348.5M
$928.4M
Q3 24
$345.5M
$883.1M
Q2 24
$336.2M
$905.4M
Net Profit
HAE
HAE
WES
WES
Q1 26
$97.3M
Q4 25
$44.7M
$190.7M
Q3 25
$38.7M
$339.6M
Q2 25
$34.0M
$341.7M
Q1 25
$58.0M
$309.0M
Q4 24
$37.5M
$333.6M
Q3 24
$33.8M
$288.5M
Q2 24
$38.4M
$378.6M
Gross Margin
HAE
HAE
WES
WES
Q1 26
14.9%
Q4 25
59.7%
Q3 25
59.5%
Q2 25
59.8%
Q1 25
58.4%
Q4 24
55.5%
Q3 24
54.2%
Q2 24
52.0%
Operating Margin
HAE
HAE
WES
WES
Q1 26
83.4%
Q4 25
19.9%
29.7%
Q3 25
17.9%
46.4%
Q2 25
16.8%
47.2%
Q1 25
21.6%
44.7%
Q4 24
16.9%
45.9%
Q3 24
15.0%
44.8%
Q2 24
11.8%
51.9%
Net Margin
HAE
HAE
WES
WES
Q1 26
7.3%
Q4 25
13.2%
18.5%
Q3 25
11.8%
35.7%
Q2 25
10.6%
36.3%
Q1 25
17.5%
33.7%
Q4 24
10.8%
35.9%
Q3 24
9.8%
32.7%
Q2 24
11.4%
41.8%
EPS (diluted)
HAE
HAE
WES
WES
Q1 26
Q4 25
$0.95
Q3 25
$0.81
Q2 25
$0.70
Q1 25
$1.17
Q4 24
$0.74
Q3 24
$0.66
Q2 24
$0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HAE
HAE
WES
WES
Cash + ST InvestmentsLiquidity on hand
$245.4M
$819.5M
Total DebtLower is stronger
$1.2B
$8.2B
Stockholders' EquityBook value
$796.3M
Total Assets
$2.4B
$15.0B
Debt / EquityLower = less leverage
1.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HAE
HAE
WES
WES
Q1 26
$245.4M
Q4 25
$363.4M
$819.5M
Q3 25
$296.4M
$177.3M
Q2 25
$292.9M
$129.7M
Q1 25
$306.8M
$448.4M
Q4 24
$320.8M
$1.1B
Q3 24
$299.3M
$1.1B
Q2 24
$344.4M
$344.1M
Total Debt
HAE
HAE
WES
WES
Q1 26
$1.2B
Q4 25
$1.2B
$8.2B
Q3 25
$1.2B
$6.9B
Q2 25
$1.2B
$6.9B
Q1 25
$1.2B
$6.9B
Q4 24
$6.9B
Q3 24
$6.9B
Q2 24
$7.1B
Stockholders' Equity
HAE
HAE
WES
WES
Q1 26
$796.3M
Q4 25
$911.5M
Q3 25
$849.2M
Q2 25
$882.3M
Q1 25
$820.8M
Q4 24
$906.9M
Q3 24
$878.9M
Q2 24
$905.4M
Total Assets
HAE
HAE
WES
WES
Q1 26
$2.4B
Q4 25
$2.5B
$15.0B
Q3 25
$2.4B
$12.1B
Q2 25
$2.5B
$12.2B
Q1 25
$2.5B
$12.5B
Q4 24
$2.5B
$13.1B
Q3 24
$2.5B
$13.0B
Q2 24
$2.5B
$12.2B
Debt / Equity
HAE
HAE
WES
WES
Q1 26
1.53×
Q4 25
1.34×
Q3 25
1.44×
Q2 25
1.39×
Q1 25
1.49×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HAE
HAE
WES
WES
Operating Cash FlowLast quarter
$293.2M
$557.6M
Free Cash FlowOCF − Capex
$209.9M
$335.4M
FCF MarginFCF / Revenue
15.7%
32.6%
Capex IntensityCapex / Revenue
2.5%
21.6%
Cash ConversionOCF / Net Profit
3.01×
2.92×
TTM Free Cash FlowTrailing 4 quarters
$417.1M
$1.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HAE
HAE
WES
WES
Q1 26
$293.2M
Q4 25
$93.6M
$557.6M
Q3 25
$111.3M
$570.2M
Q2 25
$17.4M
$564.0M
Q1 25
$116.6M
$530.8M
Q4 24
$43.8M
$554.4M
Q3 24
$48.8M
$551.3M
Q2 24
$-27.4M
$631.4M
Free Cash Flow
HAE
HAE
WES
WES
Q1 26
$209.9M
Q4 25
$87.2M
$335.4M
Q3 25
$106.3M
$385.5M
Q2 25
$13.6M
$385.4M
Q1 25
$100.9M
$388.4M
Q4 24
$35.2M
$315.7M
Q3 24
$39.4M
$361.9M
Q2 24
$-33.1M
$419.6M
FCF Margin
HAE
HAE
WES
WES
Q1 26
15.7%
Q4 25
25.7%
32.6%
Q3 25
32.5%
40.5%
Q2 25
4.2%
40.9%
Q1 25
30.5%
42.4%
Q4 24
10.1%
34.0%
Q3 24
11.4%
41.0%
Q2 24
-9.8%
46.3%
Capex Intensity
HAE
HAE
WES
WES
Q1 26
2.5%
Q4 25
1.9%
21.6%
Q3 25
1.5%
19.4%
Q2 25
1.2%
19.0%
Q1 25
4.7%
15.5%
Q4 24
2.5%
25.7%
Q3 24
2.7%
21.5%
Q2 24
1.7%
23.4%
Cash Conversion
HAE
HAE
WES
WES
Q1 26
3.01×
Q4 25
2.09×
2.92×
Q3 25
2.88×
1.68×
Q2 25
0.51×
1.65×
Q1 25
2.01×
1.72×
Q4 24
1.17×
1.66×
Q3 24
1.44×
1.91×
Q2 24
-0.71×
1.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons